PTPRC and metastatic prostate carcinoma: Adding TRA-1-60 expression (TRA+) to the analysis (EpCAM+/CK+/CD45-/TRA+) we were only able to identify one patient with metastatic prostate cancer (out of 10) by detection of ≥5 CTCs (data not shown).